Dr. Dima Abdul Jabbar | Consultant Medical Oncologist in Abu Dhabi

Best of ESMO Breast Cancer UAE

Dr. Dima Abduljabbar participated in the prestigious Best of ESMO Breast Cancer UAE 2023, a significant event in the oncology field dedicated to sharing the latest advancements in breast cancer care. This annual meeting, held in collaboration with the European Society for Medical Oncology (ESMO), brought together experts and healthcare professionals from across the region to review and discuss key highlights from the international ESMO Breast Cancer Congress 2023. The event focused on translating cutting-edge research into clinical practice, with a strong emphasis on improving access to high-quality cancer care across the UAE. Dr. Dima Abduljabbar’s involvement reflects her ongoing commitment to medical education, evidence-based treatment, and the continuous enhancement of patient outcomes in the region. As part of a broader effort to support innovation and excellence in oncology, the event also emphasized the importance of research, multidisciplinary collaboration, and policy development to meet the growing needs of cancer patients.

Circle of Hope: A Survivorship Gathering

Location: Burjeel Medical Center – Pendulum Hall Dr. Dima Abduljabbar participated in the Circle of Hope: A Survivorship Gathering, an inspiring and supportive event dedicated to empowering individuals who have completed their cancer treatment journey. This gathering provided a compassionate space for survivors and their families to reconnect with themselves, their bodies, and their community — embracing life beyond treatment. The event featured expert-led sessions on mind-body wellness, post-treatment recovery, nutrition, emotional resilience, and intimacy. With guidance from leading healthcare professionals, the program was designed to offer practical tools and uplifting insights for survivors seeking to restore strength, confidence, and holistic health. Dr. Dima Abduljabbar contributed to the session titled “Strong Bones, Strong You,” where she spoke about the importance of bone health during and after cancer treatment — a critical but often overlooked aspect of survivorship. Her guidance highlighted the long-term impact of certain cancer therapies on bone density, and shared effective strategies for protecting bone strength through nutrition, lifestyle, and medical support. Throughout the gathering, attendees had the opportunity to engage in thoughtful discussions, explore supportive therapies, and celebrate resilience with others who understand the journey firsthand. The Circle of Hope stands as a testament to the healing power of community, education, and compassionate care — and reflects Dr. Abduljabbar’s continued commitment to whole-person wellness and patient empowerment beyond clinical treatment.

Pregnancy and Breast Cancer: Updated Clinical Guidelines Shape a New Standard of Care

Published: September 2025 Dr. Dima Abduljabbar continues to remain at the forefront of evidence-based care with a focus on complex cases at the intersection of oncology and women’s health. One area gaining renewed attention is the management of breast cancer during pregnancy, highlighted in the latest release of Green-top Guideline No. 12, developed to provide clear, multidisciplinary guidance for clinicians treating this rare but serious condition. Breast cancer is the most common cancer affecting women in the UK and many other parts of the world, with about 9% of cases diagnosed in women aged 44 and under. As more women choose to delay pregnancy, the incidence of breast cancer during pregnancy is expected to rise. Currently, 1 in 3000 pregnancies is complicated by a new diagnosis of breast cancer. Green-top Guideline No. 12—now in its third edition—addresses the nuanced care required for this unique patient population. The guideline offers a comprehensive framework for diagnosing, managing, and treating breast cancer during and immediately after pregnancy. It also includes long-term considerations for fertility preservation and family planning in women with a past breast cancer diagnosis. “These updated guidelines represent a significant step forward in supporting women who face both the joys and fears of pregnancy while battling or recovering from breast cancer,” said Dr. Dima Abduljabbar. “Our clinical decisions must be both safe and sensitive—tailored not only to cancer outcomes but also to maternal and fetal health.” Key topics from the guideline include: Diagnostic pathways that minimize fetal risk Timing and selection of chemotherapy during pregnancy Safe surgical options and anesthesia considerations Breastfeeding recommendations Fertility preservation strategies prior to cancer treatment For Dr. Dima Abduljabbar, integrating such guidelines into her clinical practice is essential. She is committed to providing compassionate, state-of-the-art care to women navigating reproductive decisions amid cancer diagnoses. As breast cancer survival rates continue to improve—with 85% of women under 39 surviving at least five years post-diagnosis—more patients are considering pregnancy after cancer. This evolving reality requires not only medical expertise but also a deep understanding of emotional, ethical, and lifestyle factors involved.

Subscribe To Our Newsletter

Copyright © Dima Abdul Jabbar. All rights reserved

Dr. Dima Abdul Jabbar | Consultant Medical Oncologist in Abu Dhabi
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.